Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FRTV1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $233,777
Award facts
- Contract value 100% obligated
- $233,777.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $233,777.40 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pens on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designations and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Zepbound (tirzepatide) is a GLP-1 receptor agonist medication used in diabetes and weight management treatments, representing the type of specialty pharmaceutical product that AmerisourceBergen routinely supplies to federal medical systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and the Defense Health Agency. AmerisourceBergen's demonstrated capability to fulfill federal pharmaceutical procurement requirements through open competition, combined with its extensive portfolio of specialty medications and medical commodities, positions it as a critical vendor within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FRTV1?
SPE2DB25FRTV1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FRTV1 worth?
The government has obligated $233,777 on SPE2DB25FRTV1.
Is contract SPE2DB25FRTV1 an order under another contract?
Yes. SPE2DB25FRTV1 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRTV1 competed?
The extent of competition for SPE2DB25FRTV1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award